City of Hope and UC Berkeley researchers unveiled a microfluidic platform to analyze single breast cells under mechanical stress, aiming to detect cancer risk at the cellular level. The approach, described in The Lancet eBioMedicine, couples individualized cell measurements with a risk readout designed for early stratification. The work targets the limitations of existing risk models that rely on population-level signals rather than cellular behavior from an individual’s tissue. By applying mechanical stress, the platform seeks to reveal how cells respond in ways that correlate with cancer propensity. The strategy reflects a broader push toward functional, assay-based risk assessment rather than purely genetic or imaging biomarkers. If validated at scale, such single-cell functional profiling could influence how high-risk patients are monitored and how preventive interventions are chosen. For biotech, the platform adds another entry point for precision prevention and companion diagnostics development tied to cell-state phenotyping.